Endotoxin Testing(Endotoxin Testing)
Analytical testing to quantify bacterial endotoxins in parenteral drugs, medical devices, and other products where endotoxin presence could cause pyrogenic reaction.
Usage Examples
- The parenteral drug product specification included endotoxin not more than 5 EU/kg per hour of infusion.
- rFC-based endotoxin testing replaced LAL for the sustainable, animal-free release testing program.
What is Endotoxin Testing?
Endotoxin testing quantifies bacterial endotoxins (lipopolysaccharides, LPS) in products administered parenterally or in contact with blood. Traditional testing uses the Limulus Amebocyte Lysate (LAL) assay derived from horseshoe crab blood; the modernized alternative is recombinant Factor C (rFC) assay offering animal-free testing. USP <85>, Ph. Eur. 2.6.14, and JP 4.01 provide compendial endotoxin test methods.
Endotoxin limits are calculated based on maximum daily dose per unit body weight (K / M formula) and are included in drug product and device specifications. Specifications for intrathecal products are tighter than intravenous; intravascular devices have route-specific limits. Pyrogen testing (rabbit pyrogen test) remains available as an alternative bacterial-endotoxin-plus-pyrogens approach but has largely been replaced by endotoxin-specific assays.
Regulatory Context
This term appears most often in cmc & manufacturing workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside USP 85, PH EUR 2 6 14, ICH Q4B.
When This Matters
- The parenteral drug product specification included endotoxin not more than 5 EU/kg per hour of infusion.
- rFC-based endotoxin testing replaced LAL for the sustainable, animal-free release testing program.
Common Mistakes
- Failing to align CMC change narratives with current CFR/ICH expectations.
- Submitting incomplete control strategy documentation.
- Separating manufacturing and regulatory review cycles too late in execution.
Related Regulations
Frequently Asked Questions
LAL uses horseshoe crab blood cells; rFC uses recombinant Factor C protein. Both detect LPS; rFC eliminates animal-derived reagents. USP accepts both methods per USP <85>; Ph. Eur. 2.6.32 is the dedicated rFC chapter. Method selection is sponsor choice with validation.
Using the K/M formula: Endotoxin Limit (EU/mL) = K / (M × dose per kg) where K is the threshold pyrogenic dose (5 EU/kg for IV products, 0.2 EU/kg for intrathecal) and M is the maximum human dose per kg body weight. Different routes have different K values.
Rarely. Bacterial endotoxin test has largely replaced rabbit pyrogen testing for endotoxin-specific concerns. Pyrogen testing may still be used when non-endotoxin pyrogens are a concern, though Monocyte Activation Test (MAT) is the modern alternative per Ph. Eur. 2.6.30.
Related Terms
Related Use Cases
Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
Compress IND prep from 8-12 weeks to under 3 weeks with AI-assisted drafting and validation
Track ICH quality guidelines automatically and get alerts when changes impact your products
Track GxP regulation changes and enforcement trends
Related Regulatory Intelligence
Related Actions
Sources & References

